Adjudera

Awarded

Cerliponasa alfa 150 mg iny perf vial

Track this recordFree account — get alerted when a contract here runs out.
Buyer
Hospital Infantil Universitario Niño Jesús
Winners
BIOMARIN PHARMACEUTICALS ESPAÑA S.L.
Contract value
€457,080
Bids received
1
Published
1 Sept 2026
Awarded
28 Aug 2026
Contract start
28 Aug 2026
Contract end
29 Aug 2027estimated
Sector
Medical equipment and pharmaceuticals
Region
Madrid
Source
Original notice on TED (603769-2026)

More awards from this buyer

AwardedBuyerWinnerContract valuePublished
Suministro de medicamento exclusivo RavulizumabHospital Infantil Universitario Niño JesúsALEXION PHARMA SPAIN, S.L.€157,77115 Sept 2026
Vosoritida 0,8 mg/ml inyectableHospital Infantil Universitario Niño JesúsBIOMARIN PHARMACEUTICALS ESPAÑA S.L.€195,5781 Sept 2026
Elosulfasa alfa 1 mg/ml inyectable 5 mlHospital Infantil Universitario Niño JesúsBIOMARIN PHARMACEUTICALS ESPAÑA S.L.€123,3621 Sept 2026
Medicamento exclusivo Setmelanotida 10 mg/ml inyectable 1 ml (envase 1 vial)Hospital Infantil Universitario Niño JesúsEUROMED PHARMA SPAIN S.L.€424,81928 Aug 2026
Material fungible asociado a bombas de infusión volumétricas mod PLUM 360Hospital Infantil Universitario Niño JesúsICU MEDICALPRODUCTOS FARMACEÚTICOS Y HOSPITALARIOS, S.L.€139,91827 Aug 2026
Suministro de medicamento exclusivo RavulizumabHospital Infantil Universitario Niño JesúsALEXION PHARMA SPAIN, S.L.€157,77111 Aug 2026